{"id":69564,"date":"2024-11-01T00:00:00","date_gmt":"2024-11-01T00:00:00","guid":{"rendered":"https:\/\/www.pharmacie-vezere.com\/promotions\/lacquisition-de-dermavant-elargit-le-portefeuille-dermatologique-dorganon\/"},"modified":"2024-12-13T09:06:48","modified_gmt":"2024-12-13T09:06:48","slug":"lacquisition-de-dermavant-elargit-le-portefeuille-dermatologique-dorganon","status":"publish","type":"post","link":"https:\/\/www.pharmacie-vezere.com\/promotions\/lacquisition-de-dermavant-elargit-le-portefeuille-dermatologique-dorganon\/","title":{"rendered":"L&#8217;acquisition de Dermavant \u00e9largit le portefeuille dermatologique d&#8217;Organon."},"content":{"rendered":"<p>L&#8217;organisme de r\u00e9glementation am\u00e9ricain examine \u00e9galement une demande compl\u00e9mentaire pour le VTAMA, une cr\u00e8me comme traitement potentiel de la dermatite atopique. Cr\u00e9dit : iced.espresso\/Shutterstock.<\/p>\n<p>Organon a acquis Dermavant Sciences, une filiale de Roivant, \u00e9largissant ainsi son portefeuille en dermatologie. Avec cette acquisition, Organon ajoute \u00e0 son portefeuille la cr\u00e8me VTAMA (tapinarof) \u00e0 1 %, un traitement topique non biologique et non st\u00e9ro\u00efdien approuv\u00e9 par la FDA pour le psoriasis en plaques chez les adultes.<\/p>\n<p>La cr\u00e8me VTAMA est \u00e9galement en cours d&#8217;\u00e9valuation par le r\u00e9gulateur am\u00e9ricain pour traiter la dermatite atopique chez les adultes et les enfants de deux ans et plus. Une d\u00e9cision est attendue d&#8217;ici fin 2024.<\/p>\n<p>Selon l&#8217;accord d&#8217;acquisition sign\u00e9 en septembre 2024, Dermavant pourrait recevoir jusqu&#8217;\u00e0 1,2 milliard de dollars d&#8217;Organon, comprenant un paiement initial de 175 millions de dollars et 75 millions de dollars suppl\u00e9mentaires apr\u00e8s approbation r\u00e9glementaire. Organon versera aussi jusqu&#8217;\u00e0 950 millions de dollars de paiements suppl\u00e9mentaires li\u00e9s \u00e0 des \u00e9tapes commerciales ainsi que des redevances sur les ventes nettes.<\/p>\n<p>Le PDG d&#8217;Organon, Kevin Ali, a d\u00e9clar\u00e9 : \u00ab L&#8217;avenir de la dermatologie repose sur des traitements innovants comme VTAMA, et l&#8217;acquisition de Dermavant nous permet d&#8217;\u00e9largir notre portefeuille de marques et de traitements en dermatologie. \u00bb<\/p>\n<p>Les droits mondiaux de la cr\u00e8me VTAMA appartiennent \u00e0 Dermavant, sauf en Chine, et les droits pour le Japon ont d\u00e9j\u00e0 \u00e9t\u00e9 conc\u00e9d\u00e9s sous licence. Organon assumera \u00e9galement les dettes de Dermavant, estim\u00e9es \u00e0 environ 286 millions de dollars.<\/p>\n<p>Des conseils juridiques et financiers ont \u00e9t\u00e9 fournis par Freshfields Bruckhaus Deringer et Goldman Sachs &#038; Co pour Roivant et Covington &#038; Burling pour Organon.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L&#8217;organisme de r\u00e9glementation am\u00e9ricain examine \u00e9galement une demande compl\u00e9mentaire pour le VTAMA, une cr\u00e8me comme traitement potentiel de la dermatite atopique. Cr\u00e9dit : iced.espresso\/Shutterstock. Organon a acquis Dermavant Sciences, une filiale de Roivant, \u00e9largissant ainsi son portefeuille en dermatologie. Avec cette acquisition, Organon ajoute \u00e0 son portefeuille la cr\u00e8me VTAMA (tapinarof) \u00e0 1 %, un [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[684],"tags":[],"class_list":["post-69564","post","type-post","status-publish","format-standard","hentry","category-nouvelles-pharmaceutiques"],"_links":{"self":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/69564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/comments?post=69564"}],"version-history":[{"count":1,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/69564\/revisions"}],"predecessor-version":[{"id":69579,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/69564\/revisions\/69579"}],"wp:attachment":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/media?parent=69564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/categories?post=69564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/tags?post=69564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}